COVID-19: CDC, FDA and CMS Guidance

This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.

Safety monitoring during the first month of the COVID-19 national vaccination program shows “reassuring safety profiles” for the Pfizer and Moderna COVID-19 vaccines, the Centers for Disease Control and Prevention reported.
The Centers for Medicare & Medicaid Services extended until March 22 its guidance limiting the hospital survey process during the COVID-19 public health emergency.
CDC lifts COVID-19 quarantine requirement for fully vaccinated individuals outside health care. Get the latest guidance on quarantine for vaccinated individuals.
A report released by the Centers for Disease Control and Prevention highlights the importance of good fit to maximize mask performance.
The Food and Drug Administration authorized administering the monoclonal antibodies bamlanivimab and etesevimab together to treat patients 12 and older with mild-to-moderate COVID-19 who are at high risk for progressing to severe disease but not hospitalized or on oxygen therapy.
An estimated 68% of U.S. adults intended to receive a COVID-19 vaccine when surveyed by the Centers for Disease Control and Prevention in December, up from 61.9% in September.
The Food and Drug Administration issued updated guidance on using ventilator splitters to support more than one patient when other options are unavailable.
Lesbian, gay and bisexual persons in the U.S. have higher self-reported prevalence of several underlying health conditions associated with severe COVID-19 outcomes, compared to heterosexual persons, according to a Centers for Disease Control and Prevention study.
The Food and Drug Administration revised and reissued its emergency use authorization for COVID-19 convalescent plasma to treat hospitalized patients with COVID-19.
Between March 22 and Oct. 17, 2020, weekly COVID-19-associated hospitalization rates reported by 10 COVID-19-Associated Hospitalization Surveillance Network sites declined by 5.5 percentage points for adults under age 65 after states began mandating the use of facemasks, according to a report …